Diminished recognition of HLA-A2 proteins lacking a cytoplasmic domain (CY) by A2-restricted, EBV-specific CTLs: Possible role of the CY in TAP association

Immunogenetics

Volumn 49, Issue 4, 1999, Pages 346-350

  Cannon, Martin J ^a   Osborn, Criston K ^a   Nazaruk, Rachel A ^a   Grigoriev, Vitalii ^b,c   Crew, Mark D ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Class I; Cytoplasmic domain; Cytotoxic T lymphocyte; Major histocompatibility complex; Transporter associated with antigen processing

Indexed keywords

HLA A2 ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA SYSTEM; PRIORITY JOURNAL;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TRANSFORMED; CYTOPLASM; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HLA-A2 ANTIGEN; HUMANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032983969     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050502     Document Type: Article

References (41)

1. Capps GG, Van Kampen M, Ward CL, Zuniga MC (1989) Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-inducible pathway is a cell-specific phenomenon and requires the cytoplasmic domain. J Cell Biol 108: 1317-1329
2. Carreno BM, Solheim JC, Harris M, Stroynowski I, Connolly JM, Hansen TH (1995) TAP associates with multiple class I forms in mouse and man. J Immunol 155: 4726-4733
3. Edidin M, Zuniga MC, Sheetz MP (1994) Truncation mutants define and locate cytoplasmic barriers to lateral mobility of membrane glycoproteins. Proc Natl Acad Sci USA 91: 3378-3382
4. Edwards PAW, Smith CM, Neville AM, O'Hare MJ (1982) A human-human hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol 12: 641-648
5. Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T (1995) Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270: 105-108
6. Grandea AG, Lehner PJ, Cresswell P, Spies T (1997) Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics 46: 477-483
7. Gur H, El-Zaatari F, Geppert TD, Wacholtz MC, Taurog JD, Lipsky PE (1990) Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J Exp Med 172: 1267-1270
8. Gur H, Geppert TD, Lipsky PE (1997) Structural analysis of class I MHC molecules: the cytoplasmic domain is not required for cytoskeletal association, aggregation and internalization. Mol Immunol 34: 125-132
9. Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA (1998) The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8: 341-351
10. Khanna R, Burrows SR, Moss DJ, Silins SL (1996) Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J Virol 70: 5357-5362
11. Koller BH and Orr HT (1985) Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol 134: 2727-2733
12. Kulig K, Nandi D, Bacík I, Monaco JJ, Vukmanovic S (1998) Physical and functional association of the major histocompatibility complex class I heavy chain α3 domain with the transporter associated with antigen processing. J Exp Med 187: 865-874
13. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3: 591-600
14. Lee SP, Thomas WA, Blake NW, Rickinson AB (1996) Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur J Immunol 26: 1875-1883
15. Lehner PJ, Surman MJ, Cresswell P (1998) Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line 220. Immunity 8: 221-231
16. Li S, Sjögren H-O, Hellman U, Pettersson RF, Wang P (1997) Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc Natl Acad Sci USA 94: 8708-8713
17. 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail. J Immunol 154: 5205-5215
18. Masucci MG, Ernberg I (1994) Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol 2: 125-130
19. McMichael AJ, Parham P, Rust N, Brodsky F (1980) A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol 1: 121-129
20. + T cell response to Epstein-Barr virus. Graduate Thesis, University of Arkansas for Medical Sciences, Little Rock
21. + T cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 91: 3875-3883
22. Neisig A, Wubbolts R, Zang X, Melief C, Neefjes J (1996) Allelespecific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 156: 3196-3206
23. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368: 864-867
24. Ortmann B Copeman J, Lehner PJ, Sadasivan B, Herbert JA, Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell P (1997) A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309
25. Osborn CK, Grigoriev V, Crew MD (1997) Modulation of class I major histocompatibility complex antigen cell-surface stability by transmembrane domain length variation. Mol Immunol 34: 771-780
26. Parham P, Brodsky FM (1983) Partial purification and some properties of BB7.2. Hum Immunol 3: 227-229
27. Parham P, Barnstable CJ, Bodmer WF (1979) Use of monoclonal antibody (w6/32) in structural studies of HLA-A, B, C antigens. J Immunol 123: 342-349
28. Peace-Brewer AL, Tussey LG, Matsui M, Li, G, Quinn DG, Frelinger JA (1996) A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4: 505-514
29. RUSS G, Esquivel F, Yewdell JW, Cresswell P, Spies T, Bennink JR (1995) Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J Biol Chem 270: 21312-21318
30. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell, P (1996) Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114
31. Salter RD, Howell DN, Cresswell P (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246
32. b heavy chains. Mol Immunol 27: 169-175
33. 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 158: 2236-2241
34. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P (1987) NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138: 1657-1659
35. Su W-K, Doyle-Cohen MF, Fruh K, Wang K, Peterson PA, Williams DB (1994) Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264: 1322-1326
36. Sugita M, Jackman RM, van Donselaar E, Behar SM, Rogers RA, Peters PJ, Brenner MB, Porcelli SA (1996) Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 273: 349-352
37. Suh W-K, Mitchell EK, Yang Y, Peterson PA, Waneck GL, Williams DB (1996) MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extra-cellular domains. J Exp Med 184: 337-348
38. Vega MA, Strominger JL (1989) Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracy-toplasmic tail that shares structural features with other endocytosed molecules. Proc Natl Acad Sci USA 86: 2688-2692
39. Wei ML, Cresswell P (1992) HLA-A2 molecules in an antigen processing mutant cell contain signal sequence-derived peptides. Nature 356: 443-446
40. Zemmour J, Little A-M, Schendel DJ, Parham P (1992) The HLA-A, B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 148: 1941-1948
41. Zuniga MC, Malissen B, McMillan M, Brayton PR, Clark SS, Forman J, Hood L (1983) Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell 34: 535-544